Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. BiomX's Pre-Tax Income for the
three
months ended in Sep. 2024 was $9.64 Mil. BiomX's Revenue for the
three
months ended in Sep. 2024 was $0.00 Mil. Therefore, BiomX's pretax margin for the quarter that ended in Sep. 2024 was %.
The historical rank and industry rank for BiomX's Pretax Margin % or its related term are showing as below:
PHGE's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -148.6 * Ranked among companies with meaningful Pretax Margin % only.
BiomX Pretax Margin % Historical Data
The historical data trend for BiomX's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, BiomX's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BiomX's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BiomX's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where BiomX's Pretax Margin % falls into.
BiomX Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
BiomX's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BiomX (AMEX:PHGE) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
BiomX Pretax Margin % Related Terms
Thank you for viewing the detailed overview of BiomX's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PHGE has been successfully added to your 